血尿酸水平与接受康复治疗的缺血性卒中患者功能预后的关系
Relationship between Serum Uric Acid Level and Functional Prognosis of Ischemic Stroke Patients Receiving Rehabilitation Therapy
DOI: 10.12677/ACM.2022.1281117, PDF,   
作者: 李良丽, 王振宇*:重庆医科大学附属永川医院,重庆
关键词: 缺血性卒中综合康复治疗尿酸Ischemic Stroke Synthetic Rehabilitation Therapy Uric Acid
摘要: 目的:探讨分析在接受综合康复治疗的缺血性卒中患者中,血清尿酸水平与患者出院时的功能预后的相关性。方法:选取2019年1月至2020年12月间重庆医科大学附属永川医院康复医学科收治的149例脑梗死恢复期患者,收集了包括性别和年龄在内的人口统计信息。入院后第二天收集空腹肘静脉血进行血液学检查,包括血清尿酸(serum uric acid, SUA)和血脂参数。改良Rankin量表(mRS)用于评估出院时患者的功能结局。结果:预后良好的患者(355.6 ± 87.6 umol/L)的SUA水平高于预后较差的患者(284.9 ± 86.6 umol/L, P < 0.001)。结论:在接受综合康复治疗的缺血性卒中恢复期患者中,较高的血清尿酸水平与较好的功能预后相关。
Abstract: Objective: To analyze the correlation between the serum uric acid (SUA) level and the functional recovery of patients with ischemic stroke who received synthetic rehabilitation therapy. Methods: We recruited 149 patients with cerebral infarction in recovery period admitted to the Department of Rehabilitation Medicine, Yongchuan Hospital Affiliated to Chongqing Medical University from January 2019 to December 2020, and collected demographic information including gender and age. On the second day after admission, fasting cubital venous blood was collected for hematological examination, including serum uric acid and blood lipid parameters. The modified Rankin Scale (mRS) was used to assess the functional outcome of patients at discharge. Results: The level of SUA in patients with good prognosis (355.6 ± 87.6 umol/L) was higher than that of patients with poor prognosis (284.9 ± 86.6 umol/L, P < 0.001). Conclusion: In patients with ischemic stroke in recovery period receiving comprehensive rehabilitation therapy, higher SUA levels are associated with bet-ter functional prognosis.
文章引用:李良丽, 王振宇. 血尿酸水平与接受康复治疗的缺血性卒中患者功能预后的关系[J]. 临床医学进展, 2022, 12(8): 7751-7756. https://doi.org/10.12677/ACM.2022.1281117

参考文献

[1] Bowman, G.L., Shannon, J., Frei, B., Kaye, J.A. and Quinn, J.F. (2010) Uric Acid as a CNS Antioxidant. Journal of Alzheimer’s Disease, 19, 1331-1336. [Google Scholar] [CrossRef
[2] Méndez-Hernández, E., Salas-Pacheco, J., Ruano-Calderón, L., Téllez-Valencia, A., Cisneros-Martínez, J., Barraza-Salas, M., et al. (2015) Low-er Uric Acid Linked with Cognitive Dysfunction in the Elderly. CNS & Neurological Disorders Drug Targets, 14, 564-566. [Google Scholar] [CrossRef] [PubMed]
[3] Liu, H., Reynolds, G.P., Wang, W. and Wei, X. (2018) Lower Uric Acid Is Associated with Poor Short-Term Outcome and a Higher Frequency of Posterior Arterial Involvement in Ischemic Stroke. Neurological Sciences, 39, 1117-1119. [Google Scholar] [CrossRef] [PubMed]
[4] Ya, B.L., Liu, Q., Li, H.F., Cheng, H.J., Yu, T., Chen, L., et al. (2018) Uric Acid Protects Against Focal Cerebral Ischemia/Reperfusion-Induced Oxidative Stress via Activating Nrf2 and Regulating Neurotrophic Factor Expression. Oxidative Medicine and Cellular Longevity, 2018, Article ID: 6069150. [Google Scholar] [CrossRef] [PubMed]
[5] Zhang, B., Yang, N., Lin, S.P. and Zhang, F. (2016) Suitable Concen-trations of Uric Acid Can Reduce Cell Death in Models of OGD and Cerebral Ischemia-Reperfusion Injury. Cellular and Molecular Neurobiology, 37, 931-939. [Google Scholar] [CrossRef] [PubMed]
[6] Bonita, R. and Beaglehole, R. (1988) Recovery of Motor Func-tion after Stroke. Stroke, 19, 1497-1500. [Google Scholar] [CrossRef
[7] Faralli, A., Bigoni, M., Mauro, A., Rossi, F. and Carulli, D. (2013) Noninvasive Strategies to Promote Functional Recovery after Stroke. Neural Plasticity, 2013, Article ID: 854597. [Google Scholar] [CrossRef] [PubMed]
[8] Castrén, E. and Antila, H. (2017) Neuronal Plasticity and Neurotrophic Factors in Drug Responses. Molecular Psychiatry, 22, 1085-1095. [Google Scholar] [CrossRef] [PubMed]
[9] Pa-salic, D., Marinkovic, N. and Feher-Turkovic, L. (2012) Uric Acid as one of the Important Factors in Multifactorial Dis-orders—Facts and Controversies. Biochemia Medica, 22, 63-75. [Google Scholar] [CrossRef
[10] Ste-phen, W.W., McKnight, J.A., Webb, D.J. and Maxwell, S.R.J. (2006) Uric Acid Restores Endothelial Function in Pa-tients with Type 1 Diabetes and Regular Smokers. Diabetes, 55, 3127-3132. [Google Scholar] [CrossRef] [PubMed]
[11] Molino-Lova, R., Prisco, D., Pasquini, G., Vannetti, F., Paperini, A., Zip-oli, R., Luisi, M.L.E., Cecchi, F. and Macchi, C. (2013) Higher Uric Acid Levels Are Associated with Better Functional Recovery in Elderly Patients Receiving Cardiac Rehabilitation. Nutrition, Metabolism and Cardiovascular Diseases, 23, 1210-1215. [Google Scholar] [CrossRef] [PubMed]
[12] Chamorro, Á., Obach, V., Cervera, Á., Revilla, M., Deulofeu, R. and Aponte, J.H. (2002) Prognostic Significance of Uric Acid Serum Concentration in Patients with Acute Ischemic Stroke. Stroke, 33, 1048-1052. [Google Scholar] [CrossRef] [PubMed]
[13] Amaro, S., Urra, X., Gómez-Choco, M., Obach, V., Cervera, A., Vargas, M., Torres, F., Rios, J., Planas, A.M. and Chamorro, A. (2011) Uric Acid Levels Are Relevant in Patients with Stroke Treated with Thrombolysis. Stroke, 42, S28-S32. [Google Scholar] [CrossRef
[14] Sun, Z., Feng, J., He, M., Wang, M., Zhang, Y., Wang, N., Liu, T. and Zhang, G. (2020) Higher Uric Acid Is Associated with Better Discharge Recovery and Short-Term Out-come in Stroke Patients Treated with Thrombolysis. Neurological Sciences, 42, 3225-3231. [Google Scholar] [CrossRef] [PubMed]
[15] Weir, C.J., Muir, S.W., Walters, M.R. and Lees, K.R. (2003) Serum Urate as an Independent Predictor of Poor Outcome and Future Vascular Events after Acute Stroke. Stroke, 34, 1951-1956. [Google Scholar] [CrossRef
[16] Dawson J., Lees K.R., Weir C.J., Quinn, T., Ali, M., Hennerici, M.G. and Walters, M.R. (2009) Baseline Serum Urate and 90-Day Functional Outcomes following Acute Is-chemic Stroke. Cerebrovascular Diseases, 28, 202-203. [Google Scholar] [CrossRef] [PubMed]
[17] Yang, Y., Zhang, Y., Li, Y., Ding, L., Sheng, L., Xie, Z. and Wen, C. (2018) U-Shaped Relationship Between Functional Outcome and Serum Uric Acid in Ischemic Stroke. Cellular Physiol-ogy and Biochemistry, 47, 2369-2379. [Google Scholar] [CrossRef] [PubMed]